Vontier Appoints Rasha Hasaneen as Chief Innovation and Growth Officer
Go back to Vontier Appoints Rasha Hasaneen as Chief Innovation and Growth Officer| Savient Pharmaceuticals, Inc. (NYSE: VNT) | Delayed: 32.29 +0.08 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.21 | 52 Week High | $9.92 | |||
| Open | $32.07 | 52 Week Low | $9.10 | |||
| Day High | $32.31 | P/E | N/A | |||
| Day Low | $31.90 | EPS | $-0.94 | |||
| Volume | 59,160 | |||||
